Related Experiment Video
Updated: Jan 9, 2026
06:18
Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR
Published on: July 11, 2025
766
An objective Bayesian analysis of a crossover design via model selection and model averaging
1Department of Mathematical Sciences, University of Cincinnati, Cincinnati, 45221, OH, U.S.A.
Statistics in Medicine
|July 2, 2016
Summary
This study introduces an objective Bayesian approach for analyzing two-period crossover trials, effectively handling carryover effects and estimating treatment effects. The method improves upon standard frequentist approaches for robust clinical trial analysis.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Statistical Inference
Background:
- Crossover designs are valuable in clinical trials but face challenges due to potential carryover effects.
- The presence and magnitude of carryover effects can be influenced by treatment effects, adding complexity to analysis.
Purpose of the Study:
- To develop and evaluate a Bayesian approach for estimating treatment effects in two-period crossover designs.
- To account for uncertainty regarding the existence and size of carryover effects, alongside treatment and period effects.
Main Methods:
- An objective Bayesian methodology was employed for hypothesis testing and estimation of treatment effects.
- The approach assumes a normally distributed response variable and incorporates uncertainty about carryover effects.
Main Results:
- The proposed Bayesian method was compared against a standard frequentist approach.
- Performance was evaluated using both simulated and real-world clinical trial data.
Conclusions:
- The Bayesian approach offers a robust framework for analyzing crossover trials with potential carryover effects.
- This method provides a reliable way to estimate treatment effects amidst design complexities.
Related Concept Videos
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
164
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
164
01:16Crossover Experiments
4.5K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.5K
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
463
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
463
01:24One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
1.1K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
1.1K
01:20Comparing the Survival Analysis of Two or More Groups
538
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
538
01:21Friedman Two-way Analysis of Variance by Ranks
467
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
467